Surgical Risk: Why the Procedure Changes the Assessment
The same patient is not equally safe for cataract surgery and open aortic repair. Surgical risk is a separate axis from patient risk — and the procedure itself shapes how the cardiac assessment runs.
Key points
- Surgical risk and patient risk are two independent axes. The procedure carries its own MACE risk, regardless of how fit the patient is.
- Procedures group as low (<1% MACE), intermediate, and high (>5%) risk. Major vascular, intrathoracic, and major intra-abdominal surgery sit at the high end.
- The same cardiac history means something different for a skin excision than for open aortic repair. Surgical risk sets the threshold for further evaluation.
- High-risk procedures (open aortic, CEA, EVAR/TEVAR) raise the value of functional capacity assessment and biomarkers; low-risk surgery rarely needs either.
- Surgical risk is one axis — combine it with patient risk and functional capacity rather than reading it alone.
When to use this page
When deciding how much cardiac evaluation a given operation warrants. When the same patient is reassuring for one procedure but not another. When you want to understand why vascular and thoracic surgery trigger more workup than superficial procedures.
Surgical risk is a separate axis from patient risk
Key point
Perioperative risk has two independent inputs: how risky the procedure is, and how much cardiovascular reserve the patient has. The procedure carries its own major adverse cardiac event (MACE) risk that does not disappear because the patient is fit. Keep the two axes apart, then combine them.
A healthy patient undergoing open aortic repair faces a different absolute risk than the same patient undergoing cataract surgery. The cardiovascular stress of the operation — fluid shifts, blood loss, aortic clamping, the inflammatory response, duration — is a property of the procedure, not the patient. This is why the same cardiac history leads to different decisions depending on what surgery is planned.
Procedures group into low, intermediate, and high surgical risk
Surgical risk is conventionally stratified by the 30-day MACE risk associated with the procedure type:
- Low risk (MACE < 1%): ophthalmologic, superficial, breast, dental, most endoscopic and minor orthopedic procedures
- Intermediate risk (MACE 1–5%): intraperitoneal, head and neck, major orthopedic, carotid endarterectomy, endovascular aneurysm repair
- High risk (MACE > 5%): open aortic and major vascular surgery, open lower-limb revascularization, prolonged procedures with major fluid shifts
Exact thresholds and category boundaries vary between guidelines, and individual procedures shift with technique and institution. The grouping matters more than the precise percentage: it sets how aggressively the patient side needs to be evaluated.
Major vascular surgery sits at the high end for a reason
Key point
Major vascular surgery — open aortic repair, carotid endarterectomy, EVAR and TEVAR — concentrates cardiac risk because the patient population and the physiologic insult both point the same way. These patients usually have diffuse atherosclerosis, and the procedures impose large hemodynamic swings.
Open aortic repair combines aortic cross-clamping, large fluid shifts, and a population with a high prevalence of coronary disease. Carotid endarterectomy (CEA) carries both cardiac and cerebrovascular risk. EVAR and TEVAR are less invasive than open repair, but they are still performed in patients with a high atherosclerotic burden — so the patient-side assessment remains important even when the procedural insult is smaller. Intrathoracic surgery adds the physiologic load of one-lung ventilation and large intrathoracic pressure changes.
Surgical risk sets the threshold for further evaluation
Key point
The higher the surgical risk, the more a reduced or uncertain functional capacity matters, and the more a biomarker or echocardiogram can change the plan. For low-risk surgery, the same uncertainties rarely change management.
- Low-risk surgery → additional cardiac testing is rarely needed, even with some patient-side risk factors
- Intermediate-to-high risk surgery + reduced or unknown functional capacity → assess functional capacity, and consider BNP / NT-proBNP
- High-risk surgery → the threshold to assess functional capacity, measure biomarkers, and involve cardiology is lower
Surgical risk is never read alone
A patient with several risk factors undergoing low-risk surgery may proceed with no further testing, while the same patient undergoing high-risk surgery may warrant functional capacity assessment, biomarkers, and specialist input. The procedure and the patient combine — the assessment is about the combination, not either axis by itself. This is also why high-risk surgery is itself one of the six RCRI factors: the procedure axis is built into the patient-level score.
Common mistakes
- ✗ Assessing the patient without anchoring to the planned procedure (a fit patient still faces procedural risk)
- ✗ Ordering the same workup regardless of surgical risk (low-risk surgery rarely needs it)
- ✗ Treating EVAR/TEVAR as low risk because they are less invasive (the patient population is still high risk)
- ✗ Reading surgical risk as a stand-alone verdict instead of combining it with patient risk and functional capacity
Basis for this approach
ACC/AHA 2014 Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery (surgical risk estimation) / ESC 2022 Guidelines on Cardiovascular Assessment and Management of Patients Undergoing Non-cardiac Surgery (procedure-related risk) / JCS 2022 Guidelines on Perioperative Cardiovascular Evaluation for Non-cardiac Surgery
Continue learning
Dyspnea on Stairs: Is Functional Capacity Really Adequate?
Patients often report that they are 'active' or 'walking regularly.' That does not mean they have adequate functional capacity. This case teaches how to move from symptom to functional limitation to perioperative decision.
Elevated BNP Before Surgery: A Signal, Not a Diagnosis
BNP 250 pg/mL. An elevated BNP does not diagnose heart failure. It signals that cardiac stress may be present. The key question is why it is elevated.
A Prior PCI Is Not the Whole Story: Assessing Coronary Disease Before Surgery
When a patient has a history of PCI, the first question is not about antiplatelet therapy. The first question is whether coronary artery disease remains stable today.
Apply this in practice
Procedure risk known → combine surgical risk, FC, and RCRI in the Navigator
Verify this decision in the tool →